PLAUR and metabolic syndrome: Unlike senolytic approaches based on small molecules, uPAR CAR T cells have long-lasting effects after the administration of a single low dose, causing a marked impairment in age-induced or HFD-induced metabolic syndrome when mice were treated during youth or administration of HFD, respectively.